DONATE

Cellular and molecular mechanobiology

ABOUT

Tissues in our body can be extremely soft such as breast or brain, or very stiff such as bone. Cells in our body constantly interact mechanically with such tissues, exerting, transmitting, withstanding, and detecting forces. This mechanical interaction with the environment regulates how cells proliferate, differentiate, and move, and regulates development, tumorigenesis or wound healing. 

Our research aims at unraveling – and re-engineering – the molecular mechanisms by which cells detect and respond to mechanical stimuli like forces or tissue rigidity, triggering downstream cell responses. 

Just like biochemical stimuli initiate signaling cascades, mechanical forces affect the links and conformation of a network of molecules connecting cells to the extracellular matrix. This molecular and cellular response to force constitutes the phenomenon of mechanotransduction. 

To study mechanotransduction, we combine biophysical techniques like magnetic and optical tweezers, Atomic Force Microscopy, traction microscopy, and microfabricated force sensors with molecular biology, advanced optical microscopy, and theoretical modelling. 

Sensing the environment: Using this multi-disciplinary approach, we have unveiled a molecular mechanism that cells employ to detect and respond to the rigidity of their environment, which could be crucial in breast tissue and breast cancer (Elosegui-Artola et al., 2016 Nat. Cell Biol., and Elosegui-Artola et al. 2014, Nature Mater.). This mechanism is mediated by what is known as a “molecular clutch”: in a surprising analogy with a car engine, cells can be understood as a molecular network that can engage and disengage from its environment, just as the clutch of a car. This affects force transmission from the environment to cells, and also within different cell components. We are also expanding on the idea of the molecular clutch, to explore how cell molecular engines sense not only mechanical rigidity, but other important parameters from their environment: for instance, the composition and distribution of ligands in the extracellular matrix, or other cells. In this regard, we uncovered that this concept can explain how cells sense the spatial distribution of ligands in the extracellular matrix (Oria et al., Nature 2017). We have also demonstrated that cell-cell force transmission, mediated by a molecular clutch, is essential for cells to sense gradients in stiffness (Sunyer et al., Science 2016, in collaboration with the group of Xavier Trepat).

Nuclear mechanotransduction: Forces applied to cells are transmitted all the way to the cell nucleus, where they affect its function. We are studying how this force transmission affects the dynamics of transcriptional regulators, such as YAP (Elosegui-Artola et al., 2017, Cell), and how this affects cell function.

The membrane as a mechanosensor: Due to its mechanical properties, the plasma membrane itself can respond to forces and act as a mechanosensor. Recently, we have shown that cell membranes can use purely physical principles to adapt their shape in response to mechanical forces (Kosmalska et al., 2015, Nat. Commun.). We are currently studying how cells harness this physical membrane behavior to respond to signals from their environment.

Ultimately, when we determine the molecular mechanisms that communicate cells with their environment, we will understand how forces determine development when things go right, and tumor formation when they go wrong.

Video: How tissue stiffness activates cancer

STAFF

The following is a list of the current staff members of the research group:

Pere Roca-Cusachs Soulere

Group Leader
+34 934 020 863
procaibecbarcelona.eu

PROJECTS

NATIONAL PROJECTSFINANCERPI
MECNUC · Estudio del control mecánico de la localización nuclear de proteínas (2020-2023)MINECO
Retos investigación: Proyectos I+D
Pere Roca-Cusachs
BLOCMEC Development of small molecules to block mechanotransduction for pancreatic cancer therapy (2021-2023)MICIU, Proyectos Pruebas de ConceptoPere Roca-Cusachs
INTROPY INhibiting mechanoTRansduction for Oncology theraPY (2021-2023)ACCIO, Tecniospring IndustryMamatha Nijaguna
INTERNATIONAL PROJECTSFINANCERPI
MECHANOCONTROL · Mechanical control of biological function (2017-2021)European Commission, FET ProactivePere Roca-Cusachs
TALVIN · Inhibiting mechanotransduction for the treatment of pancreatic cancer (2018-2021)European Commission, FET Innovation LaunchpadPere Roca-Cusachs
MECHANOSITY Mechanical regulation of cellular behaviour in 3D viscoelastic materials (2019-2022)European Commission, MARIE CURIEAlberto Elosegui
PRIVATELY-FUNDED PROJECTSFINANCERPI
Mech4Cancer · Enabling technologies to map nuclear mechanosensing: from organoids to tumors (2020-2023)Obra Social La Caixa
Health Research Call
Pere Roca-Cusachs
Understanding YAP-mediated mechanotransduction in pancreatic cancer (2020-2023)Fundació La Marató de TV3Pere Roca-Cusachs
Understanding and measuring mechanical tumor properties to improve cancer diagnosis, treatment, and survival: Application to liquid biòpsies (2017-2022)Obra Social La Caixa Pere Roca-Cusachs
FINISHED PROJECTSFINANCERPI
Desarrollo de una terapia innovadora para el tratamiento de los tumores sólidos mediante la inhibición de la mecanotransducción (2018-2020)MINECO, Subprograma Retos-ColaboraciónPere Roca-Cusachs
Understanding and measuring mechanical tumor properties to improve cancer diagnosis, treatment, and survival: Application to liquid biopsies (2017-2020)Obra Social La CaixaPere Roca-Cusachs
IMREG El sistema acoplado entre integrinas y proteínas adaptadoras como regulador mecánico del comportamiento celular (2016-2020)MINECO, Proyectos I+D Excelencia
Pere Roca-Cusachs
MECHANOMEMBRANE Redes mecanoquímicas en la membrana plasmática (2017-2018)MINECO, Subprograma Estatal de Generación de Conocimiento “EUROPA EXCELENCIA”Pere Roca-Cusachs
Stromal stiffness in tumor progression (2014-2017)Fundació La Marató de TV3Pere Roca-Cusachs
MECBIO Red de Excelencia en Mecanobiología (2014-2016)MINECO, Subprograma Estatal de Generación de Conocimiento “REDES DE EXCELENCIA”Pere Roca-Cusachs
Inhibiting mechanostransduction as a novel therapy in the treatment of solid tumors (2017-2018)Obra Social La CaixaPere Roca-Cusachs

PUBLICATIONS

Click here for a list of publications by Pere Roca-Cusachs with IBEC affiliation.

Click here for a full list of publications including those affiliated to other organisations.

EQUIPMENT

  • Confocal Microcopy
  • Traction Microscopy
  • Live cell fluorescence microscopy
  • Cell stretching
  • Cell culture
  • Magnetic Tweezers
  • Atomic Force Microscopy
  • Surface Micro/Nano-patterning
  • Optical tweezers

COLLABORATIONS

  • Dr. Nils Gauthier 
    Mechanobiology Institute, Singapore 
  • Prof. Miguel Ángel del Pozo 
    Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 
  • Prof. Marino Arroyo 
    UPC, Barcelona 
  • Prof. Ada Cavalcanti 
    University of Heidelberg, Germany 
  • Satyajit Mayor 
    National Centre for Biological Sciences, Bangalore, India 
  • Sergi Garcia-Manyes 
    King’s College, London, UK 
  • Louise Jones 
    Barts Cancer Institute, London, UK 
  • Aránzazu del Campo 
    INM Saarbrücken, Germany 
  • Patrick Derksen 
    UMC Utrecht, the Netherlands  
  • Johanna Ivaska 
    University of Turku, Finland  
  • Jacco van Rheenen 
    Netherlands Cancer Institute, Netherlands  
  • Isaac Almendros and Ramon Farré 
    UB, Barcelona 
  • Marc Martí-Renom 
    CNAG, Barcelona  
  • Marc Güell 
    UPF, Barcelona 
  • Francisco Real 
    CNIO, Madrid 
  • Jonas Ries 
    Max Perutz labs, Vienna 

Clinical collaborations

  • University Medical Centre Utrecht 
  • Vall d’hebron Institute of Oncology 

NEWS

IBEC senior researcher Pere Roca-Cusachs has been awarded an ERC Proof of Concept Grant. This is a prestigious grant awarded by the European Research Council to explore the commercial and societal potential of research projects carried out at European institutions. Roca-Cusachs’ project, INTROPY, focuses on the inhibition of mechanotransduction as a potential therapy against cancer or fibrosis.

INTROPY: A new approach to cancer therapy by inhibiting mechanotransduction

IBEC senior researcher Pere Roca-Cusachs has been awarded an ERC Proof of Concept Grant. This is a prestigious grant awarded by the European Research Council to explore the commercial and societal potential of research projects carried out at European institutions. Roca-Cusachs’ project, INTROPY, focuses on the inhibition of mechanotransduction as a potential therapy against cancer or fibrosis.

The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.

IBEC and VHIR hold a collaboration day to promote synergies

The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.

An IBEC-led study has revealed how mesenchymal stem cells respond to the viscosity of their environment, a key aspect in their differentiation process. The research, published in Nature Communications, provides new insights that could revolutionise the design of biomaterials for regenerative medicine applications.

Viscosity of materials key to cell differentiation

An IBEC-led study has revealed how mesenchymal stem cells respond to the viscosity of their environment, a key aspect in their differentiation process. The research, published in Nature Communications, provides new insights that could revolutionise the design of biomaterials for regenerative medicine applications.

IBEC’s 17th Annual Symposium focused on ‘Bioengineering for Emergent and Advanced Therapies’, one of IBEC’s key application areas. Around 300 people attended the event, including local and international researchers. It was a multidisciplinary environment in which experts from other centres and the IBEC community itself had the opportunity to present their projects and share knowledge.

Bioengineering for Emergent and Advanced Therapies at the 17th IBEC Symposium

IBEC’s 17th Annual Symposium focused on ‘Bioengineering for Emergent and Advanced Therapies’, one of IBEC’s key application areas. Around 300 people attended the event, including local and international researchers. It was a multidisciplinary environment in which experts from other centres and the IBEC community itself had the opportunity to present their projects and share knowledge.

IBEC researcher Pere Roca-Cusachs has been awarded the “ICREA Academia” distinction by the Catalan Institution for Research and Advanced Studies (ICREA). The leader of IBEC’s Cellular and Molecular Mechanobiology group received the award in the Life & Medical Sciences category.

Pere Roca-Cusachs receives ICREA Acadèmia program distinction for the second time

IBEC researcher Pere Roca-Cusachs has been awarded the “ICREA Academia” distinction by the Catalan Institution for Research and Advanced Studies (ICREA). The leader of IBEC’s Cellular and Molecular Mechanobiology group received the award in the Life & Medical Sciences category.

Today, on March 14th, the joint ICMS-IBEC symposium took place. This event was co-organized by IBEC and the Institute for Complex Molecular Systems (ICMS). Throughout the conference, researchers from both IBEC and ICMS presented their areas of research, aiming to enhance the scientific collaboration between the two institutions.

IBEC and ICMS reunite once more at their Annual Collaborative Symposium

Today, on March 14th, the joint ICMS-IBEC symposium took place. This event was co-organized by IBEC and the Institute for Complex Molecular Systems (ICMS). Throughout the conference, researchers from both IBEC and ICMS presented their areas of research, aiming to enhance the scientific collaboration between the two institutions.

The BIST Forum has discussed how excellent science enhances the development of society and economic growth. The event was attended by the President of the Catalan Government, the Mayor of Barcelona, the heads of the highest economic institutions and the rectors of the main universities. At the event, the new BIST IGNITE projects for multidisciplinary research were announced, three of which have the participation of IBEC.

BIST Forum, a meeting to highlight the value of frontier research

The BIST Forum has discussed how excellent science enhances the development of society and economic growth. The event was attended by the President of the Catalan Government, the Mayor of Barcelona, the heads of the highest economic institutions and the rectors of the main universities. At the event, the new BIST IGNITE projects for multidisciplinary research were announced, three of which have the participation of IBEC.

1 2 3 4

JOBS